Literature DB >> 5571456

Hypercalcaemia in patients with advanced mammary cancer.

C S Galasko, J I Burn.   

Abstract

Hypercalcaemia and hypercalciuria are common complications of advanced mammary cancer. Of 127 patients with the disease 63 (49.5%) had some abnormality of calcium balance. Eighteen (14%) of these patients developed severe progressive hypercalcaemia and became acutely ill.Most patients had skeletal metastases, and the usual cause of hypercalcaemia was rapid destruction of bone by the cancer. One patient with severe uncontrollable hypercalcaemia and minimal skeletal involvement probably developed the complication due to inappropriate secretion of a parathyroid-hormone-like substance by massive hepatic deposits.Severe hypercalcaemia was controlled successfully in 13 of the 18 patients, the serum calcium levels returning to normal and the acute symptoms disappearing. Unfortunately, successful correction of the hypercalcaemia rarely was followed by prolonged survival from the underlying malignant disease. The incidence of subsequent objective response to pituitary ablation was less than usual, and only three patients survived for more than one year after the episode of hypercalcaemia.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5571456      PMCID: PMC1798799          DOI: 10.1136/bmj.3.5774.573

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Hypercalcemia in carcinoma of the breast.

Authors:  A G JESSIMAN; K EMERSON; R C SHAH; F D MOORE
Journal:  Ann Surg       Date:  1963-03       Impact factor: 12.969

2.  Some problems of hyperparathyroidism.

Authors:  C E DENT
Journal:  Br Med J       Date:  1962-12-08

3.  STUDIES IN PARATHYROID PHYSIOLOGY: III. The Effect of Phosphate Ingestion in Clinical Hyperparathyroidism.

Authors:  F Albright; W Bauer; D Claflin; J R Cockrill
Journal:  J Clin Invest       Date:  1932-03       Impact factor: 14.808

4.  Flame photometry.

Authors:  I MACINTYRE
Journal:  Adv Clin Chem       Date:  1961       Impact factor: 5.394

5.  Fatal hypercalcaemia complicating carcinoma of breast, resistant to cortisone and phosphate administration.

Authors:  V Parsons; G Stirling; E Knight
Journal:  Br Med J       Date:  1967-12-16

6.  Thyrocalcitonin and bone resorption. Studies employing a tissue culture bioassay.

Authors:  L G Raisz; W Y Au; J Friedman; I Niemann
Journal:  Am J Med       Date:  1967-11       Impact factor: 4.965

7.  Hypercalcemia of malignant disease.

Authors: 
Journal:  Calif Med       Date:  1967-07

8.  Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.

Authors:  A J Donovan; J E Bethune; T V Berne
Journal:  Am Surg       Date:  1966-10       Impact factor: 0.688

9.  Steroid-resistent hypercalcaemia and parathyroid hyperplasia in non-osseous cancer.

Authors:  B J Grimes; B Fisher; F Finn; T S Danowski
Journal:  Acta Endocrinol (Copenh)       Date:  1967-11

10.  Phosphate treatment of hypercalcaemia due to carcinoma.

Authors:  N Thalassinos; G F Joplin
Journal:  Br Med J       Date:  1968-10-05
View more
  11 in total

1.  Calcium metabolism in breast cancer.

Authors:  R C Coombes; T J Powles; D G Joplin
Journal:  Proc R Soc Med       Date:  1977-03

Review 2.  Incidence and pathophysiology of hypercalcemia.

Authors:  G R Mundy
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

Review 3.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 4.  Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.

Authors:  T J Powles
Journal:  Proc R Soc Med       Date:  1977-03

Review 5.  [Ectopic paraneoplastic endocrinopathies associated with water-electrolyte balance disorders].

Authors:  K Hayduk; W Kaufmann
Journal:  Klin Wochenschr       Date:  1973-04-15

6.  Skeletal metastases and mammary cancer.

Authors:  C S Galasko
Journal:  Ann R Coll Surg Engl       Date:  1972-01       Impact factor: 1.891

7.  Fatal irreversible hypercalcaemia in breast cancer.

Authors:  M Cornbleet; P K Bondy; T J Powles
Journal:  Br Med J       Date:  1977-01-15

8.  Effects of inhibition of microtubule assembly on bone mineral release and enzyme release by human breast cancer cells.

Authors:  G Eilon; G R Mundy
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  Immune suppression, gliomas, and tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1972-02-05

10.  Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.

Authors:  A Valentin-Opran; G Eilon; S Saez; G R Mundy
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.